°èÇÇ À¯µµÃ¼ 2'-benzoyloxycinnamaldehyde°¡ °æ±¸ÆíÆò»óÇǾÏÁ¾ YD-10B ¼¼Æ÷ÀÇ ¼¼Æ÷»ç¸ê°ú ÀÚ°¡Æ÷½Ä À¯µµ
Cinnamaldehyde Derivative, 2'-benzoyloxycinnamaldehyde (BCA), Induces Apoptosis and Autophagy in Human Oral Squamous Carcinoma YD-10B Cells
¼Ò¼Ó »ó¼¼Á¤º¸
±èÇö¿ì:Kim Hyun-Woo
±è¼ö¾Æ:Kim Soo-A/±Ç¼º¹Î:Kwon Seong-Min/À±Á¤ÈÆ:Yoon Jung-Hoon/ÀÌÁÖ¿ë:Lee Joo-Young/¾È»ó°Ç:Ahn Sang-Gun
KMID : 0829220140380050247
Abstract
Cinnamaldehyde is known to have the antitumor effects in vitro and in vivo. In this study, we showed a potent and irreversible cytotoxic activity of the Cinnamaldehyde derivative 2'-benzoyloxycinnamaldehyde (BCA) in human Squamous oral cell carcinoma cell, YD-10B. BCA induced YD-10B cell apoptosis in a dose-responsive manner. BCA-induced apoptosis was associated with corresponding increases in a series of key components in the mitochondria-mediated apoptosis pathways, followed by caspase cleavage and PARP activation. We also observed that BCA induced autophagy through Akt/mTOR pathway in YD-10B cells. BCA treatment increased LC3B-II expression, and induced the formation of autophagosomes and autophagic vacuoles. These experimental findings suggest that BCA is a potent inhibitor of cell proliferation in YD-10B cells and provide new insights about leading to the possible development of a new therapeutic agent.
Å°¿öµå
2'-benzoyloxycinnamaldehyde; Oral cancer cell; Cell cycle; Apoptosis; Autophagy
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸